Related Experiment Video

Updated: Aug 25, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Non-HDL cholesterol as a measure of atherosclerotic risk

Chris J Packard1, Yasushi Saito

  • 1University Department of Pathological Biochemistry, Glasgow Royal Infirmary, Scotland, UK.

Journal of Atherosclerosis and Thrombosis
|April 7, 2004
PubMed

Insights

Elevated triglycerides and low HDL-C are common in Japanese patients with coronary heart disease. Non-HDL-C effectively measures atherogenic lipoproteins and predicts cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Metabolic Syndrome Research

Background:

  • Elevated triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) are characteristic of the atherogenic lipid profile in metabolic syndrome and type 2 diabetes.
  • These lipid abnormalities are frequently observed in Japanese patients diagnosed with coronary heart disease (CHD).
  • Mild to moderate hypertriglyceridemia leads to the accumulation of very-low-density lipoprotein (VLDL) and atherogenic triglyceride-rich remnant particles.

Purpose of the Study:

  • To highlight the significance of non-high-density lipoprotein cholesterol (Non-HDL-C) as a measure of atherogenic lipoproteins.
  • To emphasize the predictive value of Non-HDL-C for future cardiovascular risk.
  • To advocate for the adoption of Non-HDL-C as a secondary treatment target in patients with elevated TG.

Main Methods:

  • The study reviews existing literature and clinical guidelines concerning lipid profiles and cardiovascular risk.
  • It focuses on the role of Non-HDL-C in assessing the cholesterol content of all atherogenic lipoproteins, including TG-rich remnants.
  • The abstract references the National Cholesterol Education Program Adult Treatment Panel III recommendations.

Main Results:

  • Non-HDL-C quantifies the cholesterol in all atherogenic lipoproteins, encompassing the risk from TG-rich remnants beyond low-density lipoprotein cholesterol (LDL-C).
  • Non-HDL-C levels are a strong predictor of future cardiovascular events, irrespective of existing vascular disease.
  • Non-HDL-C was recently recommended as a secondary treatment target for patients with elevated TG.

Conclusions:

  • Non-HDL-C offers a comprehensive assessment of atherogenic lipoprotein burden.
  • Utilizing Non-HDL-C can improve the management of dyslipidemia and reduce cardiovascular risk in a significant patient population.
  • Wider adoption of Non-HDL-C measurement is crucial for enhancing CHD prevention strategies.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...